Synergy between a collagen IV mimetic peptide and a somatotropin-domain derived peptide as angiogenesis and lymphangiogenesis inhibitors

Peptides Derived from Type IV Collagen, CXC Chemokines, and Thrombospondin-1 Domain-Containing Proteins Inhibit Neovascularization and Suppress Tumor Growth in MDA-MB-231 Breast Cancer Xenografts

(2015) Jacob E. Koskimaki et al.   NEOPLASIA

VEGF-C Promotes Immune Tolerance in B16 Melanomas and Cross-Presentation of Tumor Antigen by Lymph Node Lymphatics

(2012) Amanda W. Lund et al.   Cell Reports

Development of a biomimetic peptide derived from collagen IV with anti-angiogenic activity in breast cancer

(2011) Elena V. Rosca et al.   CANCER BIOLOGY & THERAPY

Basic and Therapeutic Aspects of Angiogenesis

(2011) Michael Potente et al.   CELL

Anti-Angiogenic Peptides for Cancer Therapeutics

(2011) Elena V. Rosca et al.   CURRENT PHARMACEUTICAL BIOTECHNOLOGY

Small peptides derived from somatotropin domain-containing proteins inhibit blood and lymphatic endothelial cell proliferation, migration, adhesion and tube formation

(2011) Esak Lee et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

Molecular mechanisms of lymphangiogenesis in development and cancer

(2011) Imke Albrecht et al.   INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY

Combination Treatment with HER-2 and VEGF Peptide Mimics Induces Potent Anti-tumor and Anti-angiogenic Responsesin Vitroandin Vivo

(2011) Kevin C. Foy et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Novel Peptide-Specific Quantitative Structure–Activity Relationship (QSAR) Analysis Applied to Collagen IV Peptides with Antiangiogenic Activity

(2011) Corban G. Rivera et al.   JOURNAL OF MEDICINAL CHEMISTRY

Molecular mechanisms and clinical applications of angiogenesis

(2011) Peter Carmeliet et al.   NATURE

Antiangiogenic therapy: impact on invasion, disease progression and metastasis

(2011) John M. L. Ebos et al.   Nature Reviews Clinical Oncology

Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases

(2011) Peter Carmeliet et al.   NATURE REVIEWS DRUG DISCOVERY

Focal adhesion kinase and its signaling pathways in cell migration and angiogenesis

(2010) Xiaofeng Zhao et al.   ADVANCED DRUG DELIVERY REVIEWS

Pentastatin-1, a collagen IV derived 20-mer peptide, suppresses tumor growth in a small cell lung cancer xenograft model

(2010) Jacob E Koskimaki et al.   BMC CANCER

Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method

(2010) T.-C. Chou   CANCER RESEARCH

Evading tumor evasion: Current concepts and perspectives of anti-angiogenic cancer therapy

(2010) Amir Abdollahi et al.   DRUG RESISTANCE UPDATES

Issues regarding improving the impact of antiangiogenic drugs for the treatment of breast cancer

(2009) Robert S. Kerbel   BREAST

Silencing or Fueling Metastasis with VEGF Inhibitors: Antiangiogenesis Revisited

(2009) Sonja Loges et al.   CANCER CELL

FLT3 inhibition and mechanisms of drug resistance in mutant FLT3-positive AML

(2009) Ellen Weisberg et al.   DRUG RESISTANCE UPDATES

Vascular Endothelial Growth Factor (VEGF) Receptor-2 Tyrosine 1175 Signaling Controls VEGF-induced von Willebrand Factor Release from Endothelial Cells via Phospholipase C-γ1- and Protein Kinase A-dependent Pathways

(2009) Yan Xiong et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Integrins

(2008) Rita Silva et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

A systematic methodology for proteome-wide identification of peptides inhibiting the proliferation and migration of endothelial cells

(2008) E. D. Karagiannis et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA